Arrhythmogenic Cardiomyopathy

Overview

Arrhythmogenic cardiomyopathy (ACM) is an inherited heart muscle disease in which the muscle tissue of the right ventricle is gradually replaced by fatty or fibrous tissue over time. This structural change can disrupt the heart's electrical system and create conditions for dangerous rhythm disturbances. In some patients, the left ventricle may also become involved.

ACM is one of the most important causes of sudden cardiac arrest in young athletes and active individuals. The disease tends to follow a silent course and may produce no symptoms for years. In some people, sudden cardiac arrest is the first sign. For this reason, family screening is of life-saving importance.

ACM is most often an inherited condition. First-degree relatives of an affected person carry a meaningful risk. With early diagnosis and appropriate treatment, the risk of sudden cardiac arrest can be substantially reduced and most people can lead a normal life.

Symptoms

A significant number of people with arrhythmogenic cardiomyopathy may have no symptoms for a long period of time. When symptoms do appear, they are often related to physical exertion. The type and severity of symptoms can vary considerably from one person to another.

• Palpitations or irregular heartbeat. This is one of the most frequently reported symptoms. The heart may feel as though it is racing, fluttering, or beating out of rhythm. Palpitations may become more noticeable during or after exercise.
• Dizziness or lightheadedness. A feeling of unsteadiness or dizziness may occur, particularly during or immediately after physical activity.
• Fainting. Loss of consciousness during or after exercise is a particularly important warning sign in arrhythmogenic cardiomyopathy. It should always be taken seriously and evaluated without delay.
• Shortness of breath. Some people may find breathing more difficult during physical activity. In more advanced cases, breathlessness can also occur at rest.
• Fatigue and weakness. An unexplained and persistent sense of tiredness may occasionally be noticed.
• Chest discomfort. Some people may notice a feeling of pressure or tightness in the chest.

When to Seek Medical Care

See a doctor if you notice any of the following.

• Palpitations or a sensation of irregular heartbeat
• Dizziness or lightheadedness during or after exercise
• Unexplained fatigue or exercise capacity that seems lower than it should be
• A family history of arrhythmogenic cardiomyopathy or unexplained sudden cardiac death at a young age warrants evaluation even without symptoms

Call emergency services immediately if you experience any of the following.

• Fainting or nearly fainting, especially during or after exercise
• A very rapid or markedly irregular heartbeat
• Sudden, severe chest pain
• Sudden, severe shortness of breath

Causes

Arrhythmogenic cardiomyopathy is caused almost exclusively by inherited changes in genes that code for proteins called desmosomes. Desmosomes are specialized structures that bind heart muscle cells together. When these connections are disrupted by a gene change, the heart muscle cells are more vulnerable to damage under stress. Over time, damaged muscle tissue may be replaced by fatty or fibrous tissue, which disrupts the normal electrical pathways of the heart.

The condition follows an autosomal dominant inheritance pattern, meaning that a person who carries the gene change has approximately a 50 percent chance of passing it to each of their children. Even among family members who carry the same gene change, however, the severity and presentation of the disease can vary considerably. Some carriers may never develop noticeable symptoms.

High-intensity and competitive sport is thought to accelerate the progression of the disease. People who have engaged in vigorous training for many years before receiving a diagnosis may present earlier and with a more advanced form of the condition.

Risk Factors

• Family history of arrhythmogenic cardiomyopathy. Having a first-degree relative with the diagnosis, or a family history of unexplained sudden cardiac death at a young age, significantly increases the risk. Family screening is essential in this setting.
• A positive genetic test result. A person found to carry a relevant gene change requires regular cardiac monitoring even if heart abnormalities have not yet developed, as the condition can manifest later in life.
• High-intensity competitive sport. In people who are not yet aware of their diagnosis, vigorous exercise may accelerate disease progression and increase the risk of sudden cardiac arrest.
• Male sex. Arrhythmogenic cardiomyopathy occurs in both sexes, but serious rhythm disturbances and the risk of sudden cardiac arrest may be higher in men.

Diagnosis

ACM can be challenging to diagnose. In its early stages, findings may be minimal or may overlap with those of other conditions. Diagnosis therefore does not rest on a single test but on the combined assessment of multiple criteria. An internationally recognized set of diagnostic criteria guides this evaluation.

• Medical history and physical examination. The doctor asks in detail about when symptoms began and in what situations they occur. A history of exercise-related palpitations, dizziness, or fainting is particularly important. Family history of arrhythmogenic cardiomyopathy, unexplained sudden cardiac death, or heart failure at a young age is specifically noted. The physical examination is often normal, which does not exclude the diagnosis.
• Electrocardiogram (ECG). Several ECG findings are associated with arrhythmogenic cardiomyopathy. T-wave inversions in the right precordial leads are a common finding. The epsilon wave, a small notch appearing just after the QRS complex, is considered quite specific to this condition. Right bundle branch block may also be present. The ECG can appear entirely normal in early-stage disease, and a normal ECG does not rule out the diagnosis.
• Holter monitor. A portable ECG device worn for 24 hours or longer that continuously records the heart rhythm during daily activity. In arrhythmogenic cardiomyopathy, ventricular ectopic beats with a left bundle branch block morphology and brief runs of ventricular tachycardia may be captured. These findings both support the diagnosis and play an important role in assessing the risk of sudden cardiac arrest. Holter monitoring should be performed in any patient with palpitations or unexplained syncope.
• Echocardiogram (heart ultrasound). This evaluates the size, wall motion, and function of the right ventricle. In arrhythmogenic cardiomyopathy, regional wall motion abnormalities, enlargement, or reduced function of the right ventricle may be found. In early-stage disease, the right ventricle may appear entirely normal. Left ventricular involvement is also assessed.
• Cardiac MRI. This is the most informative imaging test for arrhythmogenic cardiomyopathy. It provides highly detailed images of the right ventricular wall structure and motion. Using late gadolinium enhancement, it can identify areas of fatty infiltration or fibrosis in both the right and left ventricles. This finding both supports the diagnosis and reflects the extent of structural damage. Cardiac MRI is critical for clarifying the diagnosis in cases where echocardiography findings are equivocal or insufficient.
• Signal-averaged ECG. A specialized technique that detects very small electrical abnormalities not visible on a standard ECG. These findings, known as late potentials, are among the recognized diagnostic criteria for arrhythmogenic cardiomyopathy.
• Exercise stress test. Heart rhythm and electrical activity are monitored during physical exertion. Exercise-induced ventricular arrhythmias may be detected, contributing both to the diagnosis and to the risk assessment.
• Genetic testing and family screening. A blood or saliva sample is tested for gene changes associated with the condition. The most commonly affected genes encode desmosomal proteins including desmoplakin, plakophilin, desmoglein, and desmocollin. A positive result supports the diagnosis and identifies family members who should be evaluated. First-degree relatives — parents, siblings, and children — should undergo cardiology assessment and echocardiography. A negative genetic test does not rule out the condition if clinical findings are present. Because not all gene changes have been identified, clinical screening of relatives should continue even when a specific mutation is not found in the family.

Treatment

Treatment of arrhythmogenic cardiomyopathy has two primary goals. The first is to prevent sudden cardiac arrest. The second is to relieve symptoms and preserve heart function. Treatment is individualized based on each patient's risk profile and the stage of the disease.

Preventing Sudden Cardiac Arrest

• Implantable cardioverter-defibrillator (ICD). This is the most effective means of preventing sudden cardiac arrest in arrhythmogenic cardiomyopathy. The small device implanted under the chest skin monitors the heart rhythm continuously. If a life-threatening rhythm such as ventricular fibrillation or sustained ventricular tachycardia is detected, it delivers an electrical shock to restore a normal rhythm. The ICD decision is based on each patient's individual risk profile. Key factors include a prior cardiac arrest or sustained ventricular tachycardia, a history of unexplained syncope, extensive right ventricular involvement, left ventricular involvement, and widespread fibrosis on cardiac MRI. The device remains in place permanently and the battery is replaced as needed.
• Exercise restriction. High-intensity and competitive sport is strongly discouraged in arrhythmogenic cardiomyopathy because vigorous exertion can increase the risk of dangerous arrhythmias and sudden cardiac arrest. This recommendation applies to all patients with the diagnosis, whether or not they have symptoms. Feeling well does not override this restriction. Which physical activities are appropriate should be determined by the cardiologist.

Managing Rhythm Disturbances

• Antiarrhythmic medications. These are used to reduce the frequency and severity of ventricular arrhythmias. Beta-blockers are typically the first choice. By slowing the heart rate, they can suppress exercise-triggered arrhythmias. Sotalol, which combines beta-blocking and antiarrhythmic properties, is frequently used in this condition. Amiodarone is a more potent antiarrhythmic agent reserved for more resistant cases or for patients experiencing frequent ICD shocks. Antiarrhythmic medications do not eliminate arrhythmias entirely. They reduce risk and help decrease the frequency of ICD shocks.
• Catheter ablation. Thin catheters are passed through blood vessels in the groin into the heart, and the electrical pathways are mapped in detail. Once the source of the arrhythmia is identified, radiofrequency energy delivered through the catheter tip selectively destroys the responsible tissue. In arrhythmogenic cardiomyopathy, catheter ablation is used in patients who have an inadequate response to antiarrhythmic medications or who are experiencing frequent ICD shocks. Because the structural changes in the heart muscle can be widespread in this condition, recurrence after ablation is possible and more than one procedure may be needed. Catheter ablation does not replace an ICD and the two are often used together.

Heart Failure Treatment

In advanced stages of arrhythmogenic cardiomyopathy, particularly when the left ventricle is also involved, heart failure may develop. Standard heart failure medications are added to the treatment plan in this situation.

• ACE inhibitors, ARBs, or ARNI. These protect the heart muscle and slow adverse remodeling. They form the foundation of treatment when left ventricular function is impaired.
• Beta-blockers. Effective both for heart failure management and for suppressing rhythm disturbances.
• Diuretics. When fluid accumulation and breathlessness are present, diuretics remove excess fluid from the body and relieve symptoms.
• SGLT2 inhibitors. These may be considered in patients with left ventricular involvement and heart failure, given their proven benefit in heart failure management.

Advanced Treatments

• Heart transplantation. In end-stage arrhythmogenic cardiomyopathy that does not respond to other treatments, heart transplantation may be considered. This is most relevant in patients with extensive biventricular involvement and severe heart failure that cannot be managed with medications or device therapies.

Complications

Without adequate treatment and monitoring, arrhythmogenic cardiomyopathy can lead to serious complications.

• Sudden cardiac arrest. This is the most feared complication. In young and active individuals who are unaware of their diagnosis, dangerous ventricular arrhythmias can cause sudden cardiac arrest without prior warning. In some patients, sudden cardiac arrest is the first manifestation of the disease. This is why family screening is critically important.
• Ventricular tachycardia. Rapid rhythm disturbances originating in the lower chambers can cause palpitations, dizziness, fainting, and life-threatening events.
• Heart failure. In more advanced cases, particularly when the left ventricle is also affected, heart failure can develop. As pumping function declines, breathlessness, swelling, and fatigue may appear.
• Atrial fibrillation. Rhythm problems can also develop in the upper chambers. Atrial fibrillation may worsen symptoms and increase the risk of stroke.
• ICD shocks. In patients with an ICD, the device may deliver a shock when it detects a dangerous rhythm. These shocks are life-saving but can be distressing and may contribute to anxiety. Antiarrhythmic medications and catheter ablation are used to reduce shock frequency.

Lifestyle

Arrhythmogenic cardiomyopathy can be well managed, and with the right treatment and lifestyle adjustments, most people can lead a normal life. Some important considerations, however, directly affect safety and long-term outcomes.

Exercise and Sport

Exercise in arrhythmogenic cardiomyopathy requires careful individual guidance. High-intensity and competitive sport is strongly discouraged because vigorous exertion may increase the risk of dangerous arrhythmias and sudden cardiac arrest. This applies to all patients with the diagnosis, regardless of whether they have symptoms. Feeling well is not a reliable indicator that any level of exercise is safe.

Light to moderate activities such as brisk walking or easy cycling may be appropriate for many patients. The specific type and intensity of physical activity that is safe for you should be determined by your cardiologist.

Living with an ICD

For patients who have an ICD, some practical awareness is important. When the device delivers a shock, there may be a sudden sensation of a thump or jolt in the chest. If you receive a single shock and feel well afterward, contact your doctor to let them know. If you receive multiple shocks within a short period, seek emergency care immediately. Regular device check-up appointments are a necessary part of living with an ICD and should not be missed. When the battery runs low, a minor procedure is performed to replace the device.

Medications

Arrhythmogenic cardiomyopathy typically requires long-term or lifelong medication use. Taking medications consistently is essential. Irregular use of antiarrhythmic drugs in particular can allow rhythm disturbances to become more frequent. If a side effect is troubling you, speak with your doctor rather than stopping the medication on your own. Always inform any other treating physician about your condition and current medications before a new drug is started.

Informing Family Members

Because arrhythmogenic cardiomyopathy is an inherited condition, first-degree relatives (parents, siblings, and children) are recommended to undergo cardiology evaluation and echocardiography. Relatives in whom a relevant gene change is identified require more frequent monitoring. The disease may be present without symptoms. For this reason, screening is not a one-time event but should be repeated at regular intervals.

Emotional Wellbeing

Receiving a diagnosis of arrhythmogenic cardiomyopathy, particularly at a young age and especially for someone who is physically active, can be a profound shock. Being told to give up competitive sport, learning about the risk of sudden death, or experiencing an ICD shock can contribute to anxiety and depression. Sharing these feelings with your doctor and people you trust is important. Do not hesitate to seek professional psychological support if needed.

Regular Follow-up

Arrhythmogenic cardiomyopathy requires ongoing monitoring. Echocardiography, ECG, Holter monitoring, and cardiac MRI may be repeated at defined intervals. ICD device checks are also part of the follow-up schedule. Contact your doctor promptly or seek emergency care if any of the following develop.

• Fainting or nearly fainting, especially during or after exercise
• New or increasing palpitations
• An ICD shock
• Multiple ICD shocks within a short period
• New breathlessness or leg swelling
• Unexplained dizziness or lightheadedness

Preparing for Your Appointment

Coming prepared to an appointment for arrhythmogenic cardiomyopathy helps your doctor make a more accurate assessment and choose the most appropriate treatment for you.

What You Can Do

• Note any episodes of palpitations, dizziness, or fainting including when they occurred, what you were doing, and how long they lasted.
• Specify whether symptoms are related to exercise.
• Mention any family history of arrhythmogenic cardiomyopathy, unexplained sudden cardiac death, or heart problems at a young age.
• List all medications, supplements, and herbal products you are taking.
• Describe your exercise habits and what type of physical activity you engage in.
• If you have an ICD, bring your device card and the details of your most recent device check.
• Write your questions down before the appointment.

Questions You May Wish to Ask Your Doctor

• What is my risk of sudden cardiac arrest?
• Do I need an implantable defibrillator?
• Which antiarrhythmic medications are appropriate for me?
• Could catheter ablation be an option?
• What type and intensity of exercise is safe for me?
• Should my family members be screened?
• Is the disease likely to progress and what will determine that?
• How often do I need follow-up appointments?

Questions Your Doctor May Ask You

• Have you experienced palpitations or fainting and when did these occur?
• Are symptoms related to exercise?
• Is there a family history of arrhythmogenic cardiomyopathy or unexplained sudden cardiac death at a young age?
• What type of sport or physical activity do you do and at what intensity?
• What medications are you currently taking?
• If you have an ICD, when did you last receive a shock?
• Are you planning a pregnancy?